Lisdexamfetamine Dimesylate
NDC 65162-023, Lisdexamfetamine, capsule, from Amneal Pharmaceuticals LLC.
- Product NDC
- 65162-023
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals LLC
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA202830
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/65162-023 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LISDEXAMFETAMINE DIMESYLATE20 mg/1
Pharmacologic classes
Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65162-023-09 | 65162002309 | 90 CAPSULE in 1 BOTTLE (65162-023-09) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c11cb3b6-3dff-477b-a249-b4c3118edc5fNADAC price for package 65162002309
GET /v1/drugs/nadac/65162002309
Use it
Look up 65162-023 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65162-023 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65162-023. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.